Small-Cap Nasdaq Stocks to Watch Now! $VTAK, $BNOX, $INBS, $DYAI, $KAVL
https://thestreetreports.com/small-cap-nasdaq...ai-kavl-2/
Numerous small-cap firms listed on NASDAQ could present significant value for investors. This article offers a swift overview of five small-cap stocks on NASDAQ that might be worth considering for inclusion in watch lists.
Catheter Precision Inc. (NYSE American: VTAK), a U.S.-based medical device company specializing in electrophysiology products, recently finalized a distribution agreement with Supri Artigos Medico Artigos Hospitalares Ltda for its LockeT product in Brazil, (the first distributor in South America). Supri is recognized as a distributor and importer of medical and hospital equipment. Simultaneously, on January 22, the company announced its participation in the Sequire Investor Summit 2024. The event, scheduled from January 23-25 in San Juan, Puerto Rico, was highlighted in the news release. Furthermore, on January 25, Catheter Precision inked a distribution agreement for Turkey concerning their VIVO™ (View into Ventricular Onset). VIVO™ is a non-invasive 3D imaging system empowering physician to pinpoint the origin of ventricular arrhythmias before procedures commence.
Bionomics Limited (NASDAQ: BNOX) is currently drawing significant investor optimism within the biotech sector due to ongoing innovations in various companies. An intriguing company to monitor is Bionomics Limited. Recently, NASDAQ.com bestowed a ‘Strong Buy’ rating on its stock, coupled with an impressive target price of $8 per share, reflecting a remarkable 650% upside from the current levels. Bionomics Limited focuses on addressing two psychiatric disorders with market potential and unmet needs, namely social anxiety disorder and post-traumatic stress disorder.
Intelligent Bio Solutions Inc. (Nasdaq: INBS), a prominent medical technology company recognized for delivering rapid and non-invasive drug/healthcare testing solutions, disclosed on January 22 that its groundbreaking Intelligent Fingerprinting Drug Screening System had been chosen by DGP Plc for in-house drug testing. The firm highlighted that DGP Plc stands as a significant player in construction logistics, security, and support within the United Kingdom. It actively participates in some of the most substantial construction projects in the country.
On January 25, Intelligent Bio Solutions declared its intention to execute a 1-for-12 reverse split of its common stock, set to take effect at 5:00 pm (Eastern Time) on January 26, 2024, with expectations that the stock would attract heightened attention from investors.
Dyadic International Inc. (NASDAQ: DYAI), the global biotech company, garnered attention this week with a significant update on January 22. The company revealed its participation in the Microcap Conference scheduled from January 31 to February 1 at the Caesars Atlantic City Hotel & Casino in Atlantic City, New Jersey. Zacks Small Cap Research recently provided an in-depth analysis of the platform and the overall prospects of Dyadic International where they specified a $9 valuation for the company’s stock.
Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) announced on January 23, its decision to undergo a 1:21 reverse stock split of its outstanding and issued common stock. The split-adjusted trading of Kaival Brands Innovations Group Inc. stock commenced on January 25, 2024, with expectations that the stock would attract heightened attention from investors.
https://thestreetreports.com/small-cap-nasdaq...ai-kavl-2/
Numerous small-cap firms listed on NASDAQ could present significant value for investors. This article offers a swift overview of five small-cap stocks on NASDAQ that might be worth considering for inclusion in watch lists.
Catheter Precision Inc. (NYSE American: VTAK), a U.S.-based medical device company specializing in electrophysiology products, recently finalized a distribution agreement with Supri Artigos Medico Artigos Hospitalares Ltda for its LockeT product in Brazil, (the first distributor in South America). Supri is recognized as a distributor and importer of medical and hospital equipment. Simultaneously, on January 22, the company announced its participation in the Sequire Investor Summit 2024. The event, scheduled from January 23-25 in San Juan, Puerto Rico, was highlighted in the news release. Furthermore, on January 25, Catheter Precision inked a distribution agreement for Turkey concerning their VIVO™ (View into Ventricular Onset). VIVO™ is a non-invasive 3D imaging system empowering physician to pinpoint the origin of ventricular arrhythmias before procedures commence.
Bionomics Limited (NASDAQ: BNOX) is currently drawing significant investor optimism within the biotech sector due to ongoing innovations in various companies. An intriguing company to monitor is Bionomics Limited. Recently, NASDAQ.com bestowed a ‘Strong Buy’ rating on its stock, coupled with an impressive target price of $8 per share, reflecting a remarkable 650% upside from the current levels. Bionomics Limited focuses on addressing two psychiatric disorders with market potential and unmet needs, namely social anxiety disorder and post-traumatic stress disorder.
Intelligent Bio Solutions Inc. (Nasdaq: INBS), a prominent medical technology company recognized for delivering rapid and non-invasive drug/healthcare testing solutions, disclosed on January 22 that its groundbreaking Intelligent Fingerprinting Drug Screening System had been chosen by DGP Plc for in-house drug testing. The firm highlighted that DGP Plc stands as a significant player in construction logistics, security, and support within the United Kingdom. It actively participates in some of the most substantial construction projects in the country.
On January 25, Intelligent Bio Solutions declared its intention to execute a 1-for-12 reverse split of its common stock, set to take effect at 5:00 pm (Eastern Time) on January 26, 2024, with expectations that the stock would attract heightened attention from investors.
Dyadic International Inc. (NASDAQ: DYAI), the global biotech company, garnered attention this week with a significant update on January 22. The company revealed its participation in the Microcap Conference scheduled from January 31 to February 1 at the Caesars Atlantic City Hotel & Casino in Atlantic City, New Jersey. Zacks Small Cap Research recently provided an in-depth analysis of the platform and the overall prospects of Dyadic International where they specified a $9 valuation for the company’s stock.
Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) announced on January 23, its decision to undergo a 1:21 reverse stock split of its outstanding and issued common stock. The split-adjusted trading of Kaival Brands Innovations Group Inc. stock commenced on January 25, 2024, with expectations that the stock would attract heightened attention from investors.
